Cargando…
Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels
Antibiotic use is an essential method for the treatment of bacterial infections. In certain cases, antibiotics are not effective because of the distribution problems caused by physiological barriers in the body. Such problems are thought to be minimized by development of sustained release systems wh...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433964/ https://www.ncbi.nlm.nih.gov/pubmed/28447299 http://dx.doi.org/10.1007/s40204-017-0066-x |
_version_ | 1783236944539418624 |
---|---|
author | Mahmoudian, M. Ganji, F. |
author_facet | Mahmoudian, M. Ganji, F. |
author_sort | Mahmoudian, M. |
collection | PubMed |
description | Antibiotic use is an essential method for the treatment of bacterial infections. In certain cases, antibiotics are not effective because of the distribution problems caused by physiological barriers in the body. Such problems are thought to be minimized by development of sustained release systems which involve implantation of antibiotic loaded polymeric systems directly to the site of infection. In this work, a new composite vancomycin hydrochloride release system based on HPMC microparticles and chitosan/glycerophosphate (Ch/Gp) thermosensitive hydrogel was designed for the aim of local treatment of osteomyelitis. Vancomycin-loaded HPMC microparticles (Van-HPMCs) were prepared by spray drying method. The SEM results showed that these particles had a mean diameter of 1.5–6.4 μm with a narrow size distribution and homogeneous particle production. Their drug encapsulation efficiency was 72.6%. The Van-HPMCs were embedded in an injectable Ch/Gp solution to introduce a composite drug release platform (Van/HPMC-Ch/Gp). In vitro release studies indicated that inclusion of the Van-HPMCs into the Ch/Gp hydrogel caused a reduction in both the release rate and total amount of vancomycin release, which suggests that HPMC microparticles entrapped into the Ch/Gp hydrogels showed more suitable sustained release kinetics for local antibiotics delivery. |
format | Online Article Text |
id | pubmed-5433964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-54339642017-05-31 Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels Mahmoudian, M. Ganji, F. Prog Biomater Original Research Antibiotic use is an essential method for the treatment of bacterial infections. In certain cases, antibiotics are not effective because of the distribution problems caused by physiological barriers in the body. Such problems are thought to be minimized by development of sustained release systems which involve implantation of antibiotic loaded polymeric systems directly to the site of infection. In this work, a new composite vancomycin hydrochloride release system based on HPMC microparticles and chitosan/glycerophosphate (Ch/Gp) thermosensitive hydrogel was designed for the aim of local treatment of osteomyelitis. Vancomycin-loaded HPMC microparticles (Van-HPMCs) were prepared by spray drying method. The SEM results showed that these particles had a mean diameter of 1.5–6.4 μm with a narrow size distribution and homogeneous particle production. Their drug encapsulation efficiency was 72.6%. The Van-HPMCs were embedded in an injectable Ch/Gp solution to introduce a composite drug release platform (Van/HPMC-Ch/Gp). In vitro release studies indicated that inclusion of the Van-HPMCs into the Ch/Gp hydrogel caused a reduction in both the release rate and total amount of vancomycin release, which suggests that HPMC microparticles entrapped into the Ch/Gp hydrogels showed more suitable sustained release kinetics for local antibiotics delivery. Springer Berlin Heidelberg 2017-04-26 /pmc/articles/PMC5433964/ /pubmed/28447299 http://dx.doi.org/10.1007/s40204-017-0066-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Mahmoudian, M. Ganji, F. Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels |
title | Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels |
title_full | Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels |
title_fullStr | Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels |
title_full_unstemmed | Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels |
title_short | Vancomycin-loaded HPMC microparticles embedded within injectable thermosensitive chitosan hydrogels |
title_sort | vancomycin-loaded hpmc microparticles embedded within injectable thermosensitive chitosan hydrogels |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433964/ https://www.ncbi.nlm.nih.gov/pubmed/28447299 http://dx.doi.org/10.1007/s40204-017-0066-x |
work_keys_str_mv | AT mahmoudianm vancomycinloadedhpmcmicroparticlesembeddedwithininjectablethermosensitivechitosanhydrogels AT ganjif vancomycinloadedhpmcmicroparticlesembeddedwithininjectablethermosensitivechitosanhydrogels |